Mid career · publishing since 2009Rising activity
PARP inhibition in cancer therapyAdvanced Breast Cancer TherapiesBreast Cancer Treatment StudiesEstrogen and related hormone effectsDNA Repair Mechanisms
Publications
71
Citations
1,320
Est. group size
~10
Recurring co-author estimate
Active years
18
Publishing since 2009
In context
Among 4,491 mid career Medicine PIs within our index
Citations: 1,320p25 240 · p75 1,552 · cohort median 614
Publications / year (recent): 6.6p25 1.8 · p75 7.2 · cohort median 3.4
Typically publishes in teams of ~13 · 4% small-team papers (≤3 authors) · across 14 venues
Publication cadence
Publications per year over the last 10 years — averaging 6.6/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Unraveling the Molecular Mechanisms of Radioresistance in Breast Cancer: A Transcriptomic and Proteomic Analysis
International Journal of Radiation Oncology*Biology*Physics · 2024
- Transcriptomic Analysis to Uncover the Mechanism of Radiosensitization of AR-Positive Triple Negative Breast Cancers with AR Inhibition
International Journal of Radiation Oncology*Biology*Physics · 2023
- Supplementary Figure Captions from Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers
2023
- Supplementary Methods from Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers
2023
- Supplementary Data from Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers
2023
- Supplementary Data from Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers
2023
- Supplementary Figure Captions from Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers
2023
- Supplementary Methods from Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers
2023
- Data from Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers
2023
- Data from Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers
2023
- Figure S1 from PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
2023
- Figure S3 from PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
2023
- Table S1 from PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
2023
- Figure S2 from PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
2023
- Figure S2 from PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
2023
Publishes in
- Cancer Research×18
- International Journal of Radiation Oncology*Biology*Physics×7
- npj Breast Cancer×2
- Clinical Cancer Research×2
- Journal of Clinical Investigation×1
Similar researchers
By research-topic overlap
- Andrea M. Pesch
Medicine · University of Michigan
- Anna R. Michmerhuizen
Medicine · University of Michigan
- Nicole Hirsh
Medicine · University of Michigan
- Meilan Liu
Medicine · University of Michigan
- DM O’Malley
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile